High Purity Semax

Analytical Definition of High Purity Semax

High purity Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) manufactured to a certified purity threshold of ≥99% via solid-phase peptide synthesis (SPPS) for laboratory research use. Derived from the adrenocorticotropic hormone fragment ACTH(4-10), high purity Semax is widely utilized in preclinical studies investigating neuroprotection, central nervous system signaling, neuroplasticity, and neurotrophic factor expression. Analytical verification requires reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS) to ensure precise molecular weight matching and complete freedom from truncated peptide fragments or synthesis reagents.

When sourcing reagents for sensitive biochemical or cellular assays, reagent quality directly dictates experimental reproducibility. Lower-grade synthetic peptides often contain synthesis side-products, such as deleted sequence isomers or unblocked amino acid residues, which can confound receptor binding studies or cell culture viability assays. Utilizing a high purity Semax peptide backed by lot-specific analytical documentation ensures that observed biological responses can be definitively attributed to the target sequence rather than contaminant-driven artifacts.

Chemical Structure and Molecular Properties of Semax

Semax possesses the chemical formula C37H51N9O10S and a precise molecular weight of 813.92 g/mol. Its primary structure consists of the heptapeptide sequence Met-Glu-His-Phe-Pro-Gly-Pro. The core sequence, Met-Glu-His-Phe, corresponds to the endogenous ACTH(4-10) fragment, which historically exhibited rapid enzymatic breakdown when exposed to systemic or cellular peptidases in vitro. To overcome this metabolic instability during laboratory experimentation, chemical synthesists appended a C-terminal Pro-Gly-Pro (PGP) tripeptide motif.

This structural modification dramatically alters the molecular dynamics of the compound. The C-terminal PGP tail creates steric hindrance against carboxypeptidases and prolyl endopeptidases, significantly extending the chemical half-life of the molecule in cultured neuronal media and tissue homogenates. Researchers studying peptide kinetics routinely utilize research peptides featuring terminal stabilization motifs to preserve structural integrity throughout extended incubation periods.

The amphipathic nature of Semax—contributed by the hydrophilic Glutamic Acid and Histidine residues juxtaposed against hydrophobic Phenylalanine and Proline rings—allows the compound to interact dynamically with lipid membranes and cell-surface receptors in experimental models. Understanding these physicochemical attributes is vital when preparing stock solutions or determining partition coefficients in biophysical experiments.

Sourcing Criteria and Quality Assurance Benchmarks

Establishing rigorous quality control parameters is essential for institutional procurement teams acquiring peptides for preclinical studies. To guarantee that experimental results remain unconfounded by reagent variation, laboratories should evaluate peptide suppliers against standardized analytical benchmarks.

PX1 Research enforces strict manufacturing and testing protocols across all production runs. The following criteria represent the non-negotiable baseline for analytical-grade neuropeptide research reagents:

• RP-HPLC Purity Verification: Every production lot must demonstrate ≥99% purity by area under the curve (AUC) resolution, ensuring minimal baseline noise or co-eluting sequence variants. • ESI-MS Identity Confirmation: Electrospray ionization mass spectrometry must confirm the monoisotopic mass of 813.92 Da, verifying correct amino acid assembly without unexpected adducts. • Endotoxin Assay (LAL Test): Cell-culture grade peptides require low endotoxin levels (<0.01 EU/μg) measured via Limulus Amebocyte Lysate testing to prevent non-specific macrophage activation or immune signaling artifacts. • Third-Party Laboratory Certification: COAs must be generated by independent, ISO 17025-accredited analytical laboratories rather than internal non-validated benches. • Domestic Manufacturing & Storage: Production within cGMP-compliant US facilities prevents international transit degradation and guarantees strict environmental controls. • Lot Traceability & Same-Day Dispatch: Complete chain-of-custody tracking with same-day shipping (Monday–Friday) from California and Arizona facilities to minimize freeze-thaw exposure during logistics.

By adhering to these rigorous standards, investigators reviewing our research peptide library can confidently implement Semax into high-sensitivity biological assays, electrophysiological recordings, and transcriptomic profiling experiments.

Preclinical Mechanisms of Action and Molecular Targets

Preclinical investigation into Semax has uncovered multi-faceted neuromodulatory cascades across diverse cell lines and animal models. Rather than operating through a single classical neurotransmitter receptor, Semax appears to exert pleiotropic effects on central nervous system gene expression, neurotrophin signaling, and inflammatory signaling pathways.

A primary focus of current research revolves around the regulation of Brain-Derived Neurotrophic Factor (BDNF) and its cognate receptor, Tropomyosin receptor kinase B (TrkB). In vitro assays on rodent hippocampal cell cultures indicate that exposure to Semax triggers a rapid upregulation of BDNF mRNA transcripts and protein expression. This increase in neurotrophin synthesis is accompanied by enhanced nerve growth factor (NGF) expression, establishing Semax as a valuable chemical tool for exploring neuroplasticity mechanisms and dendritic spine remodeling.

Furthermore, transcriptomic profiling in rodent ischemic stroke models demonstrates that Semax rapidly alters the expression of genes governing vascular tone, extracellular matrix remodeling, and immune cell extravasation. Preclinical evidence suggests that Semax downregulates pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α within brain tissue homogenates following hypoxic stress. Concurrently, it upregulates vascular endothelial growth factor (VEGF) expression, providing a framework for investigating microvascular protection and post-ischemic tissue repair.

Additional laboratory assays suggest interactions with the melanocortin receptor system (specifically MC4R and MC5R) as well as modulation of the dopaminergic and serotonergic systems. Researchers evaluating central monoamine turnover have noted altered dopamine and serotonin metabolite concentrations in striatal tissue slices following peptide perfusion, making it an intriguing candidate for investigating complex neurochemical regulatory loops.

Comparative Analysis: Semax vs. Related Neuropeptides

In preclinical neuroscience, investigators frequently compare Semax against other synthetic neuropeptides sharing similar structural, neuroprotective, or regulatory targets. Evaluating these compounds side-by-side provides critical context when designing multi-arm experimental protocols.

Semax is most directly contrasted with Selank, a synthetic heptapeptide derived from the human immunomodulatory peptide Tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). While Semax incorporates the ACTH(4-10) sequence targeting BDNF expression, vascular gene regulation, and melanocortin receptors, Selank primary mechanisms revolve around GABAergic modulation, enkephalin stabilization, and immunomodulatory gene expression. For researchers exploring modified analogs, N-Acetyl Semax Amidate features N-terminal acetylation and C-terminal amidation, structural alterations designed to further increase lipophilicity and enzymatic resistance in metabolic stability assays. In broader neurobiology and longevity studies, researchers often cross-compare these regulatory peptides with metabolic regulators like Epithalon or systemic tissue-repair compounds like BPC-157 to assess overlapping cell-survival pathways.

A comprehensive summary of structural and mechanistic distinctions among these primary research compounds is provided in the comparative framework below:

Comparative Neuropeptide Profile Matrix

The following matrix outlines the key chemical and experimental parameters distinguishing Semax from related research peptides:

1. Semax (Met-Glu-His-Phe-Pro-Gly-Pro | 813.92 Da): - Primary Target/Mechanism: BDNF/TrkB upregulation, VEGF expression, melanocortin modulation, gene expression in ischemic cascades. - Key Preclinical Focus: Ischemic stroke models, neuroprotection assays, cognitive/learning paradigms in rodents. - Primary Research Area: Central nervous system neuroplasticity and cerebrovascular research. 2. N-Acetyl Semax Amidate (Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2 | 871.96 Da): - Primary Target/Mechanism: Modified end-caps for elevated enzymatic stability and enhanced lipid membrane penetration. - Key Preclinical Focus: Extended kinetics in vitro, cell-penetration efficiency assays. - Primary Research Area: Advanced peptide delivery systems and extended-duration cellular signaling. 3. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro | 751.90 Da): - Primary Target/Mechanism: Allosteric GABA-A receptor modulation, endogenous enkephalinase inhibition, interleukin regulation. - Key Preclinical Focus: Anxiolytic behavioral paradigms, immune-neural axis communication, stress response models. - Primary Research Area: Neuroimmunology and neurochemical stress response. 4. Epithalon (Ala-Glu-Asp-Gly | 390.35 Da): - Primary Target/Mechanism: Telomerase activity stimulation, chromatin structure modification, melatonin secretion regulation. - Key Preclinical Focus: Cellular senescence assays, oxidative stress resilience, lifespan extension models in rodents. - Primary Research Area: Gerontology and cellular aging research.

To review deeper mechanistic side-by-side data, consult our dedicated laboratory analysis comparing Selank vs Semax or our broad synthesis on preclinical nootropic peptides.

Reconstitution Protocols for Laboratory Assays

Lyophilized Semax peptide is supplied as a sterile, vacuum-sealed white powder. To maintain structural integrity and ensure accurate molar concentration across experimental runs, laboratory personnel must follow standardized reconstitution procedures using aseptic techniques.

Reconstitution Volume Calculation: To prepare a standard 1.0 mM stock solution of Semax (MW = 813.92 g/mol) from a 10 mg lyophilized vial: • Target Concentration: 1.0 mM = 0.8139 mg/mL • Required Diluent Volume: 10 mg / 0.8139 mg/mL = 12.286 mL of diluent. Alternatively, for a concentrated 5.0 mg/mL stock solution: • Required Diluent Volume: 10 mg / 5.0 mg/mL = 2.0 mL of diluent.

Recommended Diluents: • Sterile Bacteriostatic Water (0.9% Benzyl Alcohol): Preferred for multi-dose laboratory sampling protocols where repeated vial penetration is required over an extended testing window. • Sterile Phosphate-Buffered Saline (PBS, pH 7.4): Preferred for cell culture assays or direct biochemical enzymatic tests where physiological osmotic pressure and pH buffering are required.

Step-by-Step Reconstitution Procedure: 1. Allow the lyophilized vial to equilibrate to room temperature (20°C–25°C) before reconstitution to prevent atmospheric condensation inside the vial. 2. Clean the rubber septum thoroughly with a 70% isopropyl alcohol wipe in a laminar flow hood. 3. Using a sterile micro-syringe, slowly inject the calculated volume of diluent down the inner glass wall of the vial. Avoid directing the liquid stream directly onto the lyophilized peptide cake. 4. Allow the diluent to wet the powder completely. Gently swirl the vial in a circular motion. Do NOT vortex or agitate vigorously, as shear forces can induce peptide aggregation or denaturation. 5. Inspect the final solution under focused illumination. High purity Semax should dissolve completely within 30–60 seconds, yielding a clear, colorless, particle-free solution.

Storage Parameters and Temperature Stability

Maintaining proper environmental controls is critical to prevent peptide degradation through hydrolysis, oxidation of the Methionine residue, or thermal cleavage of the peptide backbone.

Lyophilized Storage: Unreconstituted lyophilized Semax peptide powder should be stored at -20°C for short-to-medium duration experiments (up to 12 months) or at -80°C for long-term biobanking (up to 36 months). Desiccant packs should be kept within storage containers to mitigate ambient humidity ingress.

Reconstituted Solution Storage: Once reconstituted in sterile bacteriostatic water or buffered saline, peptide stock solutions should be divided into single-use micro-aliquots using sterile microcentrifuge tubes to prevent repeated freeze-thaw cycles. Aliquots stored at 2°C–8°C remain stable for up to 30 days. For extended preservation up to 6 months, aliquots must be frozen at -20°C or -80°C.

Avoid Freeze-Thaw Degradation: Repeated cycling between frozen and liquid states induces ice crystal formation, localized pH shifts, and mechanical shear stress that rapidly degrades peptide purity. Any aliquot subjected to more than two freeze-thaw cycles should be discarded from high-precision quantitative assays.

Analytical Verification: Interpreting HPLC and MS COAs

A Certificate of Analysis (COA) provides the definitive proof of purity, identity, and safety for a research peptide. Principal investigators and lab managers should independently verify three core analytical sections on every COA before initiating experiments:

1. Reverse-Phase HPLC Chromatogram Analysis: RP-HPLC separates molecules based on hydrophobicity using a C18 stationary column and an acetonitrile/water gradient containing 0.1% trifluoroacetic acid (TFA). The chromatogram displays a dominant sharp retention peak corresponding to intact Semax. Purity is calculated by integrating the Area Under the Curve (AUC) of the primary peak relative to secondary baseline noise peaks. A certified high purity Semax peptide must exhibit an AUC of ≥99.0%.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): ESI-MS confirms the exact mass-to-charge ratio (m/z) of the molecule. For Semax (C37H51N9O10S), the primary protonated molecular ion peak [M+H]+ appears at m/z 814.92 Da, matching the theoretical monoisotopic mass. The absence of secondary mass peaks at m/z -131 Da (loss of Methionine) or m/z -97 Da (loss of Proline) confirms the absence of truncated synthesis errors.

3. LAL Endotoxin Testing: Endotoxins (lipopolysaccharides from Gram-negative bacterial walls) trigger severe inflammatory responses in cellular and animal models. COAs must explicitly validate endotoxin limits below <0.01 EU/μg via kinetic chromogenic LAL assays, guaranteeing suitability for delicate in vitro tissue cultures.

Institutional Procurement and Wholesale Ordering

PX1 Research supports academic institutions, biotechnology companies, and contract research organizations (CROs) requiring reliable, bulk-scale peptide supplies. Institutional procurement departments benefit from streamlined ordering processes, consistent lot-to-lot purity, and comprehensive documentation for compliance audit trails.

High-volume research projects utilizing Semax across multiple laboratory arms can access customized bulk packaging, specialized aliquot sizing, and reserve-lot holding through our dedicated wholesale peptide program. All orders placed before 3:00 PM PST dispatch the same day from our domestic fulfillment centers in California and Arizona, ensuring rapid supply chain continuity for critical research timelines.